Literature DB >> 29297889

Bladder cancer: Chemotherapy and checkpoint blockade.

Clemens Thoma.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 29297889     DOI: 10.1038/nrurol.2017.224

Source DB:  PubMed          Journal:  Nat Rev Urol        ISSN: 1759-4812            Impact factor:   14.432


× No keyword cloud information.
  1 in total

1.  Phase 2 Trial of Gemcitabine, Cisplatin, plus Ipilimumab in Patients with Metastatic Urothelial Cancer and Impact of DNA Damage Response Gene Mutations on Outcomes.

Authors:  Matthew D Galsky; Huan Wang; Noah M Hahn; Przemyslaw Twardowski; Sumanta K Pal; Costantine Albany; Mark T Fleming; Alexander Starodub; Ralph J Hauke; Menggang Yu; Qianqian Zhao; Guru Sonpavde; Michael J Donovan; Vaibhav G Patel; John P Sfakianos; Josep Domingo-Domenech; William K Oh; Nicholas Akers; Bojan Losic; Sacha Gnjatic; Eric E Schadt; Rong Chen; Seunghee Kim-Schulze; Nina Bhardwaj; Andrew V Uzilov
Journal:  Eur Urol       Date:  2017-12-13       Impact factor: 20.096

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.